ArticleNPJ precision oncology2026

GLUD1 supports ovarian cancer progression by counteracting anoikis via ARAF/MEK/ERK signaling.

Huolun Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.